Andre Luis Abreu, MD

Photo of Andre Luis Abreu, MD
Title(s)Associate Professor of Clinical Urology
SchoolKeck School of Medicine of Usc
AddressNTT 7416
Health Sciences Campus
Los Angeles CA 90089-9178
Phone+1 323 865 3700
vCardDownload vCard

    Collapse Bibliographic 
    Collapse publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Image-fusion-guided focal irreversible electroporation for prostate cancer: Step-by-step technique. BJUI Compass. 2026 Aug; 7(8):e70266. Kaneko M, Inoue Y, Eskenazi F, Abreu AL. PMID: 42597345; PMCID: PMC13467490.
      View in: PubMed   Mentions:
    2. GUSL: A novel and efficient machine learning model for prostate segmentation on MRI. Comput Biol Med. 2026 Aug 15; 213:111820. Yang J, Magoulianitis V, Alexander CAC, Xue J, Kaneko M, Cacciamani G, Abreu A, Duddalwar V, Kuo CJ, Gill IS, Nikias C. PMID: 42364419.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. Partial gland ablation for radio-recurrent prostate cancer: Short-term oncological and functional outcomes. Urol Oncol. 2026 Jul; 44(7):391-399. Medina LG, Kaneko M, Ramacciotti LS, Chua K, Inoue Y, Cai J, Halteh P, Aron M, Bahn DK, Ukimura O, Gill IS, Abreu AL. PMID: 42173768.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. The learning curve of single-port extraperitoneal robotic radical prostatectomy: Initial experience and outcomes from a newly graduated fellowship-trained robotic surgeon. BJUI Compass. 2026 Mar; 7(3):e70184. Hershenhouse JS, Kim S, Gevorkyan R, Hom B, Eppler M, Ford P, Pathak R, Autorino R, Abreu A, Badani KK, Crivellaro S, Hemal S. PMID: 41822202; PMCID: PMC12975313.
      View in: PubMed   Mentions: 1  
    5. The Role of Near-Infrared Fluorescence with Indocyanine Green in Robot-Assisted Partial Nephrectomy: Results from an Updated Systematic Review and Meta-Analyses of Controlled Studies. Medicina (Kaunas). 2025 Sep 24; 61(10). Panunzio A, Orlando R, Greco F, Cerrato C, D'Elia SD, Marinaci L, Manno F, Shakir A, Battaglia M, Baccaglini W, Porcaro AB, Antonelli A, Abreu A, Tafuri A, Innovation on Surgical Excellence Research (InSuRe) Group. PMID: 41155723; PMCID: PMC12566515.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. Enhancing Readability of Lay Abstracts and Summaries for Urologic Oncology Literature Using Generative Artificial Intelligence: BRIDGE-AI 6 Randomized Controlled Trial. JCO Clin Cancer Inform. 2025 09; 9:e2500042. Ganjavi C, Layne E, Cei F, Gill K, Magoulianitis V, Abreu A, Goldenberg M, Desai MM, Gill I, Cacciamani GE. PMID: 40929631.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    7. Impact of magnetic resonance imaging visibility of prostate cancer on partial gland ablation. BJUI Compass. 2025 Aug; 6(8):e70065. Kaneko M, Ramacciotti LS, Inoue Y, Peretsman S, Cummins J, Cai J, Halteh P, Palmer S, Aron M, Ukimura O, Gill IS, Abreu AL. PMID: 40777065; PMCID: PMC12328995.
      View in: PubMed   Mentions: 1  
    8. Re: Baris Turkbey, Henkjan Huisman, Andriy Fedorov, et al. Requirements for AI Development and Reporting for MRI Prostate Cancer Detection in Biopsy-Naïve Men: PI-RADS Steering Committee, Version 1.0. Radiology 2025;315:e24014. Eur Urol. 2025 Nov; 88(5):e101-e102. Kaneko M, Magoulianitis V, Duddalwar V, Aron M, Kuo CJ, Gill IS, Abreu AL. PMID: 40544122.
      View in: PubMed   Mentions:    Fields:    
    9. The outcomes of salvage robotic radical prostatectomy following radiation versus focal therapy: Does the primary treatment modality matter? BJUI Compass. 2025 May; 6(5):e70019. Ghoreifi A, Ramacciotti LS, Kaneko M, Medina LG, Cacciamani GE, Konganige S, Aron M, Sadeghi S, Jadvar H, Djaladat H, Sotelo R, Desai MM, Gill IS, Aron M, Abreu AL. PMID: 40322501; PMCID: PMC12045929.
      View in: PubMed   Mentions:
    10. Awareness and use of generative AI-powered tools: results of one-year follow-up prospective cross-sectional global survey. Minerva Urol Nephrol. 2025 Aug; 77(4):528-537. Cei F, Ganjavi C, Layne E, Hussari T, Gevorkyan RR, Eppler M, Piazza P, Rodler S, Checcucci E, Gomez Rivas J, Kowalewski KF, Rivero Belenchón I, Puliatti S, Taratkin M, Veccia A, Baekelandt L, DE Backer P, Teoh J, Somani B, Wroclawski M, DE Castro Abreu A, Briganti A, Salonia A, Montorsi F, Porpiglia F, Murphy D, Canes D, Gill I, Cacciamani GE. PMID: 40232163.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    11. A Comparison of Stockholm3, Serum Biomarkers, and Risk Calculators to Predict Prostate Cancer in a Racially and Ethnically Diverse Cohort: Evaluation of the Stockholm3 Multiethnic SEPTA Trial. J Urol. 2025 05; 213(5):590-599. Lazarovich A, Vigneswaran H, Palsdottir T, Eklund M, Discacciati A, Nordström T, Hubbard RA, Perlis N, Abern MR, Moreira DM, Yonover P, Chow AK, Watts K, Liss MA, Thoreson GR, Abreu AL, Sonn GA, Plym A, Wiklund F, Grönberg H, Murphy AB, Eggener S. PMID: 40202133.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    12. Cellular Proliferation Imaging With 18 F-FMAU PET/CT as Adjunct to mpMRI in Image-Guided Biopsy of Suspected Prostate Cancer. Clin Nucl Med. 2025 Jun 01; 50(6):e340-e343. Jadvar H, Chen K, Mohamed P, Jadvar DS, Abreu AL. PMID: 39924745; PMCID: PMC12052491.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    13. The Safety and Feasibility of Aquablation in Patients with Previous Surgery for Benign Prostatic Hyperplasia. J Endourol. 2025 Jan; 39(1):50-55. Sanchez DE, Ghoreifi A, Storino Ramacciotti L, Cai J, Maas M, Venkat A, Lee R, Abreu AL, Cacciamani GE, Doumanian L, Gill I, Liu-Chen A, Nguyen M, Sotelo R, Desai MM. PMID: 39639800.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    14. Prostate Cancer Disparities in Clinical Characteristics and Survival among Black and Latino Patients Considering Nativity: Findings from the California Cancer Registry. Cancer Epidemiol Biomarkers Prev. 2024 11 01; 33(11):1512-1522. Freedland AR, Sanchez Mendez J, Liu L, Hamilton AS, Zhang J, Hwang AE, Ballas L, Abreu AL, Deapen D, Stern MC. PMID: 39208026; PMCID: PMC12468573.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    15. A sustainable and expedited 'One-Stop' prostate cancer diagnostic pathway to reduce environmental impact and enhance accessibility. BJUI Compass. 2024 Dec; 5(12):1278-1287. Storino Ramacciotti L, Kaneko M, Rodler S, Mohideen M, Cai J, Liang G, Aron M, Hopstone M, Stern MC, Cacciamani GE, Gill I, Abreu AL. PMID: 39744079; PMCID: PMC11685178.
      View in: PubMed   Mentions:
    16. Transperineal versus Transrectal MRI/TRUS fusion-guided prostate biopsy in a large, ethnically diverse, and multiracial cohort. Int Braz J Urol. 2024 Sep-Oct; 50(5):616-628. Ramacciotti LS, Strauss D, Cei F, Kaneko M, Mokhtar D, Cai J, Jadvar D, Cacciamani GE, Aron M, Halteh PB, Duddalwar V, Gill I, Abreu AL. PMID: 39106117; PMCID: PMC11446557.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    17. The learning curve for transperineal MRI/TRUS fusion prostate biopsy: A prospective evaluation of a stepwise approach. Urol Oncol. 2025 01; 43(1):64.e1-64.e10. Ramacciotti LS, Kaneko M, Strauss D, Hershenhouse JS, Rodler S, Cai J, Liang G, Aron M, Duddalwar V, Cacciamani GE, Gill I, Abreu AL. PMID: 39179437.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    18. Generative Artificial Intelligence Platform for Automating Social Media Posts From Urology Journal Articles: A Cross-Sectional Study and Randomized Assessment. J Urol. 2024 12; 212(6):873-881. Ramacciotti LS, Cei F, Hershenhouse JS, Mokhtar D, Rodler S, Gill K, Strauss D, Medina LG, Cai J, Abreu AL, Desai MM, Sotelo R, Gill IS, Cacciamani GE. PMID: 39141845.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    19. Salvage treatments after focal therapy for prostate cancer - a comprehensive review. Prostate Cancer Prostatic Dis. 2025 Sep; 28(3):557-571. Storino Ramacciotti L, Abreu AL, Crouzet S, Macek P, Miles BJ, Horuz R, Nunes-Carneiro D, Stricker P, Scionti S, Laguna MP. PMID: 39090369.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    20. Readability Assessment of Patient Education Materials on Uro-oncological Diseases Using Automated Measures. Eur Urol Focus. 2024 Dec; 10(6):1055-1061. Rodler S, Maruccia S, Abreu A, Murphy D, Canes D, Loeb S, Malik RD, Bagrodia A, Cacciamani GE. PMID: 39048402.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    21. Stockholm3 in a Multiethnic Cohort for Prostate Cancer Detection (SEPTA): A Prospective Multicentered Trial. J Clin Oncol. 2024 Nov 10; 42(32):3806-3816. Vigneswaran HT, Eklund M, Discacciati A, Nordström T, Hubbard RA, Perlis N, Abern MR, Moreira DM, Eggener S, Yonover P, Chow AK, Watts K, Liss MA, Thoreson GR, Abreu AL, Sonn GA, Palsdottir T, Plym A, Wiklund F, Grönberg H, Murphy AB, SEPTA STHLM3 Study Group. PMID: 39038251.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    22. Global access to technologies to support safe and effective inguinal hernia surgery: prospective, international cohort study. Br J Surg. 2024 07 02; 111(7). National Institute for Health and Care Research (NIHR) Global Health Research Unit on Global Surgery. PMID: 38985889; PMCID: PMC11235323.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    23. PCa-RadHop: A transparent and lightweight feed-forward method for clinically significant prostate cancer segmentation. Comput Med Imaging Graph. 2024 09; 116:102408. Magoulianitis V, Yang J, Yang Y, Xue J, Kaneko M, Cacciamani G, Abreu A, Duddalwar V, Kuo CJ, Gill IS, Nikias C. PMID: 38908295.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    24. Accuracy, readability, and understandability of large language models for prostate cancer information to the public. Prostate Cancer Prostatic Dis. 2025 Jun; 28(2):394-399. Hershenhouse JS, Mokhtar D, Eppler MB, Rodler S, Storino Ramacciotti L, Ganjavi C, Hom B, Davis RJ, Tran J, Russo GI, Cocci A, Abreu A, Gill I, Desai M, Cacciamani GE. PMID: 38744934; PMCID: PMC12106072.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    25. Study protocol for the Intraoperative Complications Assessment and Reporting with Universal Standards (ICARUS) global cross-specialty surveys and consensus. PLoS One. 2024; 19(4):e0297799. Cacciamani GE, Sholklapper T, Eppler MB, Sayegh A, Storino Ramacciotti L, Abreu AL, Sotelo R, Desai MM, Gill IS. PMID: 38626051; PMCID: PMC11020956.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    26. Generative artificial intelligence in surgery. Surgery. 2024 06; 175(6):1496-1502. Rodler S, Ganjavi C, De Backer P, Magoulianitis V, Ramacciotti LS, De Castro Abreu AL, Gill IS, Cacciamani GE. PMID: 38582732.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    27. Publishers' and journals' instructions to authors on use of generative artificial intelligence in academic and scientific publishing: bibliometric analysis. BMJ. 2024 01 31; 384:e077192. Ganjavi C, Eppler MB, Pekcan A, Biedermann B, Abreu A, Collins GS, Gill IS, Cacciamani GE. PMID: 38296328; PMCID: PMC10828852.
      View in: PubMed   Mentions: 48     Fields:    Translation:Humans
    28. Reply to Rui-Cheng Wu, Deng-Xiong Li, and De-Chao Feng's Letter to the Editor re: Michael Eppler, Conner Ganjavi, Lorenzo Storino Ramacciotti, et al. Awareness and Use of ChatGPT and Large Language Models: A Prospective Cross-sectional Global Survey in Urology. Eur Urol. 2024;85:146-53. Eur Urol. 2024 Mar; 85(3):e85-e86. Eppler M, Ganjavi C, Abreu A, Gill I, Cacciamani GE. PMID: 38182492.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    29. Editorial Comment. J Urol. 2024 02; 211(2):222. Ramacciotti LS, Abreu AL. PMID: 38055733.
      View in: PubMed   Mentions: 1     Fields:    
    30. The Impact of Telemedicine in Reducing the Carbon Footprint in Health Care: A Systematic Review and Cumulative Analysis of 68 Million Clinical Consultations. Eur Urol Focus. 2023 11; 9(6):873-887. Rodler S, Ramacciotti LS, Maas M, Mokhtar D, Hershenhouse J, De Castro Abreu AL, Fuchs G, Stief CG, Gill IS, Cacciamani GE. PMID: 38036339.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    31. Awareness and Use of ChatGPT and Large Language Models: A Prospective Cross-sectional Global Survey in Urology. Eur Urol. 2024 02; 85(2):146-153. Eppler M, Ganjavi C, Ramacciotti LS, Piazza P, Rodler S, Checcucci E, Gomez Rivas J, Kowalewski KF, Belenchón IR, Puliatti S, Taratkin M, Veccia A, Baekelandt L, Teoh JY, Somani BK, Wroclawski M, Abreu A, Porpiglia F, Gill IS, Murphy DG, Canes D, Cacciamani GE. PMID: 37926642.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    32. Impact of persistent PSA after salvage radical prostatectomy: a multicenter study. Prostate Cancer Prostatic Dis. 2024 Dec; 27(4):686-692. Preisser F, Incesu RB, Rajwa P, Chlosta M, Nohe F, Ahmed M, Abreu AL, Cacciamani G, Ribeiro L, Kretschmer A, Westhofen T, Smith JA, Steuber T, Calleris G, Raskin Y, Gontero P, Joniau S, Sanchez-Salas R, Shariat SF, Gill I, Karnes RJ, Cathcart P, Van Der Poel H, Marra G, Tilki D. PMID: 37803241; PMCID: PMC11543598.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    33. The Novel Green Learning Artificial Intelligence for Prostate Cancer Imaging: A Balanced Alternative to Deep Learning and Radiomics. Urol Clin North Am. 2024 Feb; 51(1):1-13. Kaneko M, Magoulianitis V, Ramacciotti LS, Raman A, Paralkar D, Chen A, Chu TN, Yang Y, Xue J, Yang J, Liu J, Jadvar DS, Gill K, Cacciamani GE, Nikias CL, Duddalwar V, Jay Kuo CC, Gill IS, Abreu AL. PMID: 37945095.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    34. Transperineal vs transrectal magnetic resonance and ultrasound image fusion prostate biopsy: a pair-matched comparison. Sci Rep. 2023 08 18; 13(1):13457. Kaneko M, Medina LG, Lenon MSL, Hemal S, Sayegh AS, Jadvar DS, Ramacciotti LS, Paralkar D, Cacciamani GE, Lebastchi AH, Salhia B, Aron M, Hopstone M, Duddalwar V, Palmer SL, Gill IS, Abreu AL. PMID: 37596374; PMCID: PMC10439224.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    35. Focal Therapy for Prostate Cancer: Getting Ready for Prime Time. Eur Urol. 2022 01; 81(1):34-36. Abreu AL, Kaneko M, Cacciamani GE, Lebastchi AH. PMID: 34740501.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    36. Techniques and Outcomes of MRI-TRUS Fusion Prostate Biopsy. Curr Urol Rep. 2021 Mar 22; 22(4):27. Kaneko M, Sugano D, Lebastchi AH, Duddalwar V, Nabhani J, Haiman C, Gill IS, Cacciamani GE, Abreu AL. PMID: 33748877; PMCID: PMC9827754.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    37. Five-alpha reductase inhibitors in men undergoing active surveillance for prostate cancer: impact on treatment and reclassification after 6 years follow-up. World J Urol. 2021 Sep; 39(9):3295-3307. Ashrafi AN, Shin T, Marien A, Clifford T, Shoji S, Iwata T, Iwata A, Oishi M, Chopra S, Cai J, Ukimura O, Bahn D, Gill IS, Abreu AL. PMID: 33683411.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    38. The Pillars for Sustained Growth of Magnetic Resonance Imaging Pathway for Prostate Cancer Diagnosis: Quality, Reproducibility, Accessibility, Cost Effectiveness, and Training. Eur Urol. 2020 04; 77(4):491-493. Abreu AL. PMID: 31982194.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    39. One-Stop MRI and MRI/transrectal ultrasound fusion-guided biopsy: an expedited pathway for prostate cancer diagnosis. World J Urol. 2020 Apr; 38(4):949-956. Tafuri A, Ashrafi AN, Palmer S, Shakir A, Cacciamani GE, Iwata A, Iwata T, Cai J, Sali A, Gupta C, Medina LG, Stern MC, Duddalwar V, Aron M, Gill IS, Abreu A. PMID: 31175460; PMCID: PMC6898759.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    40. Primary Whole-gland Cryoablation for Prostate Cancer: Biochemical Failure and Clinical Recurrence at 5.6 Years of Follow-up. Eur Urol. 2019 02; 75(2):208-214. Oishi M, Gill IS, Ashrafi AN, Lin-Brande M, Nassiri N, Shin T, Bove A, Cacciamani GE, Ukimura O, Bahn DK, Abreu ALC. PMID: 30274702; PMCID: PMC9827755.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    41. Contrast-Enhanced Transrectal Ultrasound in Focal Therapy for Prostate Cancer. Curr Urol Rep. 2018 Aug 28; 19(10):87. Ashrafi AN, Nassiri N, Gill IS, Gulati M, Park D, de Castro Abreu AL. PMID: 30155585; PMCID: PMC9084632.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    Andre's Networks
    Concepts (104)
    Derived automatically from this person's publications.
    _
    Co-Authors (34)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _